(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nov 24, 2013
0
0
In a summary of a recent guideline from the National Institute for Health and Care Excellence (NICE), published online Jan. 29 in The BMJ, recommendations are presented for the assessment and management of thyroid disease.
Mar 4, 2020
0
0
More imaging after thyroid cancer treatment identifies recurrence, but it does not always improve survival, a new study suggests.
Jul 20, 2016
0
0
The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher ...
Jun 2, 2013
0
0
In patients with advanced thyroid cancer, sunitinib, a drug approved for treatment of several other cancers, showed significant cancer-fighting activity t, a new phase 2 clinical trial has found. Results of the single-center ...
Mar 8, 2015
0
9
(Medical Xpress)—The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to a new study from researchers in the Abramson Cancer Center at the University ...
Apr 25, 2014
0
0
Radioactive iodine is to be recommended as the frontline treatment for patients with thyroid gland overactivity caused by conditions such as Graves' disease, following an evidence review led by University of Birmingham researchers.
Jan 29, 2020
0
1
I recently read that thyroid issues affect women more often than men. Can you explain what the thyroid is and how it affects my body? Can I do anything to prevent having issues with my thyroid as I age?
Aug 15, 2023
0
1
